Thoratec Corporation news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

THOR 0.0000
price chart
WILMINGTON, Del., Aug. 24, 2015 (GLOBE NEWSWIRE) -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of ...
Thoratec Corporation Names Gary Burbach President and Chief Executive Officer
PLEASANTON, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in products to treat cardiovascular disease, said today that Gary F. Burbach has been named the company's president and chief executive officer.
Insider Trade: Neil Dimick Unloaded 4786 Shares of Thoratec Corporation ...
After the disclosing of a legal document filled with U.S. Security & Exchange Commission; a insider transaction became apparent.
THOR Soars On Rumored Bid By St. Jude Medical
Thoratec Corporation (NASDAQ: THOR) shares were trading sharply higher by $9.50 (20 percent) at $58.22 in Tuesday's session.
Buyout Buzz Brings Out St. Jude Medical, Inc., Thoratec Corporation Bulls  Schaeffers Research (blog)
St. Jude Medical and Thoratec Announce Definitive Agreement  Business Wire (press release)
Thoratec Corporation (NASDAQ:THOR) Current Analyst Ratings
They now have a USD 60 price target on the stock. 09/25/2015 - Thoratec Corporation had its “neutral” rating reiterated by analysts at BTIG Research.
Thoratec And The War In Heart Pumps
In June, California-based Thoratec (NASDAQ:THOR) acquired the DuraHeart II ventricular assist system from the Japanese company Terumo for an upfront payment of $13 million and potential milestone payments of up to $43.5 million.
Thoratec Announced Study Results, Time To Book Profit?
Thoratec (NASDAQ:THOR) announced results for its HeartMate II LVAD (left ventricular assist device) from the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart ...
Should You Avoid Thoratec Corporation (NASDAQ:THOR)?
According to our comprehensive database, Eric Bannasch's Cadian Capital had the largest position in Thoratec Corporation (NASDAQ:THOR), worth close to $193 million, accounting for 6.3% of its total 13F portfolio. On Cadian Capital's heels is Jim Simons ...
Related articles »  
Why You Should Hold Your Bets On the St. Jude Medical, Inc. (STJ) and Thoratec ...
St. Jude Medical, Inc. (NYSE:STJ) recently made a buyout offer for Thoratec Corporation (NASDAQ:THOR) to the tune of $3.4 billion.
St. Jude Medical Inc Expands Portfolio of Medical Devices that Aids Heart ...  Franchise Herald
This Weeks Broker Price Targets For Thoratec Corporation (NASDAQ:THOR)
The most recently updated ratings and price targets from brokers issued for Thoratec Corporation (NASDAQ:THOR) are included below.